Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Molland, J. Molland, M. Donnellan, N. Janu, N. Janu, H. Carmalt, H. Carmalt, C. Kennedy, D. Gillett, D. Gillett (2004)
Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma.Breast, 13 5
R. Ireton, Michael Davis, J. Hengel, D. Mariner, Kirk Barnes, M. Thoreson, P. Anastasiadis, L. Matrisian, L. Bundy, L. Sealy, B. Gilbert, F. Roy, A. Reynolds (2002)
A novel role for p120 catenin in E-cadherin functionThe Journal of Cell Biology, 159
E. Rakha, M. Gill, M. El-Sayed, M. Khan, Z. Hodi, R. Blamey, A. Evans, Andrew Lee, I. Ellis (2009)
The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphologyBreast Cancer Research and Treatment, 114
W. Leeuw, G. Berx, C. Vos, J. Peterse, M. Vijver, S. Litvinov, F. Roy, C. Cornelisse, A. Cleton-Jansen (1997)
Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situThe Journal of Pathology, 183
David Arps, P. Healy, Lili Zhao, C. Kleer, J. Pang (2013)
Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breastBreast Cancer Research and Treatment, 138
M. Sharouni, E. Postma, Gisela Menezes, M. Bosch, R. Pijnappel, A. Witkamp, C. Pol, H. Verkooijen, P. Diest (2016)
High Prevalence of MRI-Detected Contralateral and Ipsilateral Malignant Findings in Patients With Invasive Ductolobular Breast Cancer: Impact on Surgical Management.Clinical breast cancer, 16 4
Sung Kim, E. Cha, C. Park, B. Kang, I. Whang, A. Lee, B. Song, Jeong-Hee Park (2011)
Imaging features of invasive lobular carcinoma: comparison with invasive ductal carcinomaJapanese Journal of Radiology, 29
R. Singhai, V. Patil, S. Jaiswal, Shital Patil, M. Tayade, Amit Patil (2011)
E-Cadherin as a diagnostic biomarker in breast cancerNorth American Journal of Medical Sciences, 3
A. Reynolds, Agnes Roczniak-Ferguson (2004)
Emerging roles for p120-catenin in cell adhesion and cancerOncogene, 23
D. Dabbs, R. Bhargava, M. Chivukula (2007)
Lobular Versus Ductal Breast Neoplasms: The Diagnostic Utility of P120 CateninThe American Journal of Surgical Pathology, 31
P. Diest (2002)
No consent should be needed for using leftover body material for scientific purposes. For.BMJ, 325 7365
R. Mann, Y. Hoogeveen, J. Blickman, C. Boetes (2007)
MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literatureBreast Cancer Research and Treatment, 107
A. Suryadevara, L. Paruchuri, Nassim Banisaeed, G. Dunnington, Krishna Rao (2010)
The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysisWorld Journal of Surgical Oncology, 8
(1997)
Simultaneous loss of Ecadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
P. Derksen, Tanya Braumuller, Eline Burg, M. Hornsveld, Elly Mesman, J. Wesseling, P. Krimpenfort, J. Jonkers (2011)
Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in miceDisease Models & Mechanisms, 4
(2013)
Loss of p120catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling
R. Schackmann, S. Klarenbeek, E. Vlug, S. Stelloo, Miranda Amersfoort, M. Tenhagen, Tanya Braumuller, J. Vermeulen, P. Groep, Ton Peeters, E. Wall, P. Diest, J. Jonkers, P. Derksen (2013)
Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling.Cancer research, 73 15
D. Sarrió, B. Pérez-Mies, D. Hardisson, G. Moreno-Bueno, A. Suárez, A. Cano, J. Martín-Pérez, C. Gamallo, J. Palacios (2004)
Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesionsOncogene, 23
M. Quan, L. Sclafani, A. Heerdt, J. Fey, E. Morris, P. Borgen (2003)
Magnetic Resonance Imaging Detects Unsuspected Disease in Patients With Invasive Lobular CancerAnnals of Surgical Oncology, 10
(2012)
World health organization classification of tumors of the breast
R. Mann (2010)
The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast.Magnetic resonance imaging clinics of North America, 18 2
A. Bharat, F. Gao, J. Margenthaler (2009)
Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.American journal of surgery, 198 4
P. Derksen, Xiaoling Liu, Francis Saridin, H. Gulden, J. Zevenhoven, B. Evers, J. Beijnum, A. Griffioen, J. Vink, P. Krimpenfort, J. Peterse, R. Cardiff, A. Berns, J. Jonkers (2006)
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.Cancer cell, 10 5
Michael Davis, A. Reynolds (2006)
Blocked acinar development, E-cadherin reduction, and intraepithelial neoplasia upon ablation of p120-catenin in the mouse salivary gland.Developmental cell, 10 1
R. Schackmann, Miranda Amersfoort, Judith Haarhuis, E. Vlug, Vincentius Halim, J. Roodhart, J. Vermaat, E. Voest, P. Groep, P. Diest, J. Jonkers, P. Derksen (2011)
Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance.The Journal of clinical investigation, 121 8
C. Boetes, J. Veltman, L. Die, P. Bult, T. Wobbes, J. Barentsz (2004)
The Role of MRI in Invasive Lobular CarcinomaBreast Cancer Research and Treatment, 86
Invasive breast cancer comprises a spectrum of histological changes with purely lobular cancer on one side and purely ductal cancer on the other, with many mixed lesions in between. In a previous study, we showed that in patients with any percentage lobular component at core needle biopsy, preoperative MRI leads to the detection of clinically relevant additional findings in a substantial percentage of patients, irrespective of the percentage of the lobular component. Detection of a small lobular component may however not be reproducible among pathologists. Loss of membrane expression of E-cadherin or p120 is useful biomarkers of ILC and may therefore support a more objective diagnosis. All patients diagnosed with breast cancer containing a lobular component of any percentage between January 2008 and October 2012 were prospectively offered preoperative MRI. Clinically relevant additional findings on MRI were verified by pathology evaluation. Expression patterns of E-cadherin and p120 were evaluated by immunohistochemistry on the core needle biopsy. MRI was performed in 109 patients. The percentage of lobular component was significantly increased in cases with aberrant E-cadherin or p120 expression (both p = <0.001). However, aberrant expression of E-cadherin and p120 was not related to the probability of detecting relevant additional MRI findings. E-cadherin and p120 did not appear to be useful objective biomarkers for predicting additional relevant findings on MRI in patients with a lobular component in the core needle of their breast cancer.
Virchows Archiv – Springer Journals
Published: Aug 4, 2017
Access the full text.
Sign up today, get DeepDyve free for 14 days.